Table of Content

1.Product Overview
1.1.Market Definition
1.2.Scope of the Market
1.2.1.Markets Covered
1.2.2.Years Considered for Study
1.2.3.Key Market Segmentations
2.Research Methodology
2.1.Objective of the Study
2.2.Baseline Methodology
2.3.Key Industry Partners
2.4.Major Association and Secondary Sources
2.5.Forecasting Methodology
2.6.Data Triangulation Validations
2.7.Assumptions and Limitations
3.Executive Summary
3.1.Overview of the Market
3.2.Overview of Key Market Segmentations
3.3.Overview of Key Market Players
3.4.Overview of Key Regions/Countries
3.5.Overview of Market Drivers, Challenges, Trends
4.Voice of Customer
5.Global Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
5.1.Market Size Forecast
5.1.1.By Value
5.2.Market Share Forecast
5.2.1.By Product (Instruments and Services, Consumables, Software)
5.2.2.By Application (HIV Testing, HSV Testing, CT/NG testing, Syphilis testing, Gonorrhea testing, Others)
5.2.3.By Technology (Immunoassay, Molecular Diagnostics, Others)
5.2.4.By Location of Testing (Laboratory Testing, Point of Care Testing, Others)
5.2.5.By Region
5.2.6.By Company (2023)
5.3.Market Map
6.North America Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
6.1.Market Size Forecast
6.1.1.By Value
6.2.Market Share Forecast
6.2.1.By Product
6.2.2.By Application
6.2.3.By Technology
6.2.4.By Location of Testing
6.2.5.By Country
6.3.North America: Country Analysis
6.3.1.United States Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
6.3.1.1.Market Size Forecast
6.3.1.1.1.By Value
6.3.1.2.Market Share Forecast
6.3.1.2.1.By Product
6.3.1.2.2.By Application
6.3.1.2.3.By Technology
6.3.1.2.4.By Location of Testing
6.3.2.Canada Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
6.3.2.1.Market Size Forecast
6.3.2.1.1.By Value
6.3.2.2.Market Share Forecast
6.3.2.2.1.By Product
6.3.2.2.2.By Application
6.3.2.2.3.By Technology
6.3.2.2.4.By Location of Testing
6.3.3.Mexico Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
6.3.3.1.Market Size Forecast
6.3.3.1.1.By Value
6.3.3.2.Market Share Forecast
6.3.3.2.1.By Product
6.3.3.2.2.By Application
6.3.3.2.3.By Technology
6.3.3.2.4.By Location of Testing
7.Europe Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
7.1.Market Size Forecast
7.1.1.By Value
7.2.Market Share Forecast
7.2.1.By Product
7.2.2.By Application
7.2.3.By Technology
7.2.4.By Location of Testing
7.2.5.By Country
7.3.Europe: Country Analysis
7.3.1.France Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
7.3.1.1.Market Size Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share Forecast
7.3.1.2.1.By Product
7.3.1.2.2.By Application
7.3.1.2.3.By Technology
7.3.1.2.4.By Location of Testing
7.3.2.Germany Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
7.3.2.1.Market Size Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share Forecast
7.3.2.2.1.By Product
7.3.2.2.2.By Application
7.3.2.2.3.By Technology
7.3.2.2.4.By Location of Testing
7.3.3.United Kingdom Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
7.3.3.1.Market Size Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share Forecasty
7.3.3.2.1.By Product
7.3.3.2.2.By Application
7.3.3.2.3.By Technology
7.3.3.2.4.By Location of Testing
7.3.4.Italy Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
7.3.4.1.Market Size Forecast
7.3.4.1.1.By Value
7.3.4.2.Market Share Forecast
7.3.4.2.1.By Product
7.3.4.2.2.By Application
7.3.4.2.3.By Technology
7.3.4.2.4.By Location of Testing
7.3.5.Spain Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
7.3.5.1.Market Size Forecast
7.3.5.1.1.By Value
7.3.5.2.Market Share Forecast
7.3.5.2.1.By Product
7.3.5.2.2.By Application
7.3.5.2.3.By Technology
7.3.5.2.4.By Location of Testing
8.Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
8.1.Market Size Forecast
8.1.1.By Value
8.2.Market Share Forecast
8.2.1.By Product
8.2.2.By Application
8.2.3.By Technology
8.2.4.By Location of Testing
8.2.5.By Country
8.3.Asia-Pacific: Country Analysis
8.3.1.India Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
8.3.1.1.Market Size Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share Forecast
8.3.1.2.1.By Product
8.3.1.2.2.By Application
8.3.1.2.3.By Technology
8.3.1.2.4.By Location of Testing
8.3.2.China Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
8.3.2.1.Market Size Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share Forecast
8.3.2.2.1.By Product
8.3.2.2.2.By Application
8.3.2.2.3.By Technology
8.3.2.2.4.By Location of Testing
8.3.3.South Korea Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
8.3.3.1.Market Size Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share Forecast
8.3.3.2.1.By Product
8.3.3.2.2.By Application
8.3.3.2.3.By Technology
8.3.3.2.4.By Location of Testing
8.3.4.Australia Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
8.3.4.1.Market Size Forecast
8.3.4.1.1.By Value
8.3.4.2.Market Share Forecast
8.3.4.2.1.By Product
8.3.4.2.2.By Application
8.3.4.2.3.By Technology
8.3.4.2.4.By Location of Testing
8.3.5.Japan Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
8.3.5.1.Market Size Forecast
8.3.5.1.1.By Value
8.3.5.2.Market Share Forecast
8.3.5.2.1.By Product
8.3.5.2.2.By Application
8.3.5.2.3.By Technology
8.3.5.2.4.By Location of Testing
9.South America Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
9.1.Market Size Forecast
9.1.1.By Value
9.2.Market Share Forecast
9.2.1.By Product
9.2.2.By Application
9.2.3.By Technology
9.2.4.By Location of Testing
9.2.5.By Country
9.3.South America: Country Analysis
9.3.1.Brazil Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
9.3.1.1.Market Size Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share Forecast
9.3.1.2.1.By Product
9.3.1.2.2.By Application
9.3.1.2.3.By Technology
9.3.1.2.4.By Location of Testing
9.3.2.Argentina Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
9.3.2.1.Market Size Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share Forecast
9.3.2.2.1.By Product
9.3.2.2.2.By Application
9.3.2.2.3.By Technology
9.3.2.2.4.By Location of Testing
9.3.3.Colombia Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
9.3.3.1.Market Size Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share Forecast
9.3.3.2.1.By Product
9.3.3.2.2.By Application
9.3.3.2.3.By Technology
9.3.3.2.4.By Location of Testing
10.Middle East and Africa Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
10.1.Market Size Forecast
10.1.1.By Value
10.2.Market Share Forecast
10.2.1.By Product
10.2.2.By Application
10.2.3.By Technology
10.2.4.By Location of Testing
10.2.5.By Country
10.3.MEA: Country Analysis
10.3.1.South Africa Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
10.3.1.1.Market Size Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share Forecast
10.3.1.2.1.By Product
10.3.1.2.2.By Application
10.3.1.2.3.By Technology
10.3.1.2.4.By Location of Testing
10.3.2.Saudi Arabia Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
10.3.2.1.Market Size Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share Forecast
10.3.2.2.1.By Product
10.3.2.2.2.By Application
10.3.2.2.3.By Technology
10.3.2.2.4.By Location of Testing
10.3.3.UAE Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
10.3.3.1.Market Size Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share Forecast
10.3.3.2.1.By Product
10.3.3.2.2.By Application
10.3.3.2.3.By Technology
10.3.3.2.4.By Location of Testing
11.Market Dynamics
11.1.Drivers
11.2.Challenges
12.Market Trends Developments
12.1.Recent Development
12.2.Mergers Acquisitions
12.3.Product Launches
13.Global Sexually Transmitted Diseases (STD) Diagnostics Market: SWOT Analysis
14.Porter?s Five Forces Analysis
14.1.Competition in the Industry
14.2.Potential of New Entrants
14.3.Power of Suppliers
14.4.Power of Customers
14.5.Threat of Substitute Products
15.Competitive Landscape
15.1.Becton Dickinson and Company
15.1.1.Business Overview
15.1.2.Company Snapshot
15.1.3.Products Services
15.1.4.Financials (As Reported)
15.1.5.Recent Developments
15.1.6.Key Personnel Details
15.1.7.SWOT Analysis
15.2.F. Hoffmann-La Roche Ltd.
15.3.Hologic, Inc.
15.4.bioM?rieux S.A.
15.5.Abbott Laboratories Inc.
15.6.Danaher Corporation
15.7.Qiagen N.V.
15.8.Thermo Fisher Scientific Inc.
15.9.DiaSorin S.p.A
15.10.Bio-Rad Laboratories, Inc.
16.Strategic Recommendations
17.About Us Disclaimer